WallStreetZenWallStreetZen

NYSEMKT: MTNB
Matinas Biopharma Holdings Revenue

OverviewEarningsRevenue
DividendOwnership
Matinas Biopharma Holdings revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MTNB annual revenue was $0.0, with -100% growth year-over-year.

MTNB past revenue growth

How has MTNB's revenue growth performed historically?

Company
-100%
Industry
497.69%
Market
20.68%
MTNB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MTNB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

MTNB revenue history

Current Revenue
$0.0
Current Earnings
-$24.3M
Current Profit Margin
0%

Be the first to know when MTNB announces revenue.

MTNB Revenue History By Year

MTNB Yearly RevenueMTNB RevenueMTNB ChangeMTNB Revenue Growth
2024-12-31$0.00-$1.10M-100.00%
2023-12-31$1.10M-$2.09M-65.62%
2022-12-31$3.19M$3.16M+9,560.61%
2021-12-31$33.00kN/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00N/AN/A
2016-12-31$0.00N/AN/A
2015-12-31$0.00N/AN/A
2014-12-31$0.00N/AN/A
2013-12-31$0.00N/AN/A

1 of 1

Matinas Biopharma Holdings Revenue FAQ

What was MTNB's revenue last quarter?

On Invalid Date, Matinas Biopharma Holdings (NYSEMKT: MTNB) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Matinas Biopharma Holdings's revenue was $0.00.

What was Matinas Biopharma Holdings's revenue in 2024?

Matinas Biopharma Holdings's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a 100% decrease year over year.

How much does Matinas Biopharma Holdings make in a day?

Based on Matinas Biopharma Holdings annual revenue for the past five years, MTNB makes an average of $2,365.48 per day.

What was Matinas Biopharma Holdings's annual revenue growth in the past year?

As of Q2 2025, Matinas Biopharma Holdings's revenue has grown -100% year over year. This is 597.69 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Matinas Biopharma Holdings's revenue in the past year totaled $0.00.

How much does Matinas Biopharma Holdings make in a year?

Matinas Biopharma Holdings's revenue by year for the past five years is:
  • Matinas Biopharma Holdings's revenue for the twelve months ending Dec 31, 2024 was $0.00, a 100% decrease year over year.
  • Matinas Biopharma Holdings's annual revenue for Dec 31, 2023 was $1.10 million, a 65.62% decrease from 2022.
  • Matinas Biopharma Holdings's annual revenue for 2022 was $3.19 million, a 9,560.61% increase from 2021.
  • Matinas Biopharma Holdings's annual revenue for 2021 was $33.00 thousand, a Infinity% increase from 2020.
  • Matinas Biopharma Holdings's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.